CLOV vs LXRX · rev $1.37B vs rev $31.1M
Clover Health Investments Corp (CLOV) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported LXRX revenue for 2024-12-31 was $31.1M. Net income was -$200.4M. Revenue was up 2481.5% from 2023-12-31 to 2024-12-31. LXRX currently screens at market cap $327.2M.
CLOV currently screens at market cap $1.55B. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the CLOV and LXRX stock pages for the full models.
Not investment advice.